Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of pain reduction between 5 mg and 10 mg triamcinolone injection in De Quervain syndrome
TCTR20221126002Phase 4Unknown
- Sponsor
- Faculty of Medicine
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone in de Quervain's tenosynovitis, sponsored by Faculty of Medicine. Status: unknown.
02
Drugs
triamcinolone
03
Conditions
de Quervain's tenosynovitis
Beyond the preview
Go deeper on TCTR20221126002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221126002.